Shanghai - Delayed Quote CNY

Guangxi Wuzhou Zhongheng Group Co.,Ltd (600252.SS)

2.2400 -0.0100 (-0.44%)
As of 11:29 AM GMT+8. Market Open.
Loading Chart for 600252.SS
DELL
  • Previous Close 2.2500
  • Open 2.2400
  • Bid 2.2300 x --
  • Ask 2.2400 x --
  • Day's Range 2.2100 - 2.2600
  • 52 Week Range 1.9000 - 2.7900
  • Volume 16,956,960
  • Avg. Volume 32,626,248
  • Market Cap (intraday) 7.731B
  • Beta (5Y Monthly) 0.39
  • PE Ratio (TTM) 112.00
  • EPS (TTM) 0.0200
  • Earnings Date --
  • Forward Dividend & Yield 0.01 (0.44%)
  • Ex-Dividend Date Jun 9, 2023
  • 1y Target Est --

Guangxi Wuzhou Zhongheng Group Co., Ltd. researches, develops, manufactures, and sells pharmaceuticals in China. The company offers xueshuantong for injection, zhonghua dieda pills, fuyanjing capsules, jieshitong tablets, yanjianning tablets, angong niuhuang pills, shedan chuanbei liquid, and fluorescein sodium injection covers range of therapeutic areas, such as cardiovascular and cerebrovascular, neurology, endocrinology, orthopedics, ophthalmology, gynecology, pediatrics, respiratory, urinary system, and other fields. It also provides toothpaste, mouthwash, mouth spray, laundry detergents, laundry beads, shower gels, Shampoos, electric toothbrush, tooth rinser, electric toothpaste, and other series of products under the Tianqi, Tianqi Doll, and Pure Cotton Era brands; and medical instruments, including mask series, protective clothing, isolation eye masks, and forehead thermometers, as well as Chinese herbal medicines. In addition, the company produces health food products under the DOUBLE MONEY brand. Additionally, it engages in the real estate development and management, and project investment. The company was founded in 1993 and is headquartered in Wuzhou, China.

www.wz-zhongheng.com

2,886

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: 600252.SS

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

600252.SS
10.76%
SSE Composite Index
1.92%

1-Year Return

600252.SS
13.16%
SSE Composite Index
8.16%

3-Year Return

600252.SS
17.15%
SSE Composite Index
12.73%

5-Year Return

600252.SS
28.59%
SSE Composite Index
5.21%

Compare To: 600252.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 600252.SS

Valuation Measures

Annual
As of 4/23/2024
  • Market Cap

    7.77B

  • Enterprise Value

    5.96B

  • Trailing P/E

    91.46

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.49

  • Price/Book (mrq)

    1.18

  • Enterprise Value/Revenue

    1.93

  • Enterprise Value/EBITDA

    17.40

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.72%

  • Return on Assets (ttm)

    -0.01%

  • Return on Equity (ttm)

    0.37%

  • Revenue (ttm)

    3.1B

  • Net Income Avi to Common (ttm)

    84.31M

  • Diluted EPS (ttm)

    0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.09B

  • Total Debt/Equity (mrq)

    21.57%

  • Levered Free Cash Flow (ttm)

    -52.41M

Company Insights: 600252.SS

People Also Watch